The PBM plans to stop requiring coverage reauthorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...

Optum Rx — which includes the pharmacy benefit manager of health care conglomerate UnitedHealth Group — is dropping annual reauthorization requirements for 80 drugs, which will eliminate more than 10% ...

The changes come as pharmacy benefit managers face scrutiny for how they require doctors and patients to seek its approval for certain treatments and drugs.

Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. | Optum Rx announced on Wednesday that it will eliminate up to 25% of ...

Prior authorization requires doctors ... benefits competitors — major PBMs including Optum have announced a number of internal changes that they say make them more straightforward and effective.

The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.

Optum Rx is shifting its payment ... The PBM said these changes will reduce its overall prior authorization requirements by about 10%. The PBM industry has been under pressure from lawmakers ...

The PBM also announced that it will make the pharmacy experience simpler for consumers with chronic conditions by eliminating ...

OptumRx will trim reauthorization requirements ... in cases of long-term safety concerns or potential dosing changes. "The prior authorization program, which I'm responsible for, always goes ...

UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get insurance authorization when renewing prescriptions on about 80 drugs, aiming to reduce ...

Optum Rx, the pharmacy benefit manager under UnitedHealth Group, is set to eliminate prior authorization requirements for approximately 80 prescription drugs in an effort to simplify access to ...